Skip to main content

  • Bioactive or Drug-Eluting Stents in 75 Years or Older Patients: The BIODES-75 Registry

    • Posted: 09/01/2022
    • Author:

      Juan G. Córdoba-Soriano, Antonio Gutiérrez-Díez, Bruno García Del Blanco, Julio Núñez, Ignacio J. Amat-Santos, Juan Francisco Oteo, Rafael Romaguera, Arsenio Gallardo-López, Fernando Lozano Ruíz-Poveda, Pascual Baello, Pablo Aguar, Miguel Jerez-Valero, Víctor Alfonso Jiménez-Díaz, Bernat Serra, Jose Domingo Cascon, Francisco J. Morales-Ponce, Juan José Portero-Portaz, Driss Melehi El Assali, Pablo Cerrato-García and Jesús Jiménez-Mazuecos

    • CRM2022

    Abstract

    Background

    TiNO-coated BAS have demonstrated competitive outcomes compared to drug-eluting stents (DES). These devices allow short antiplatelet regimens and may be a good option for the growing elderly population undergoing percutaneous coronary intervention (PCI).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details